This study tests a new drug called mitazalimab combined with standard chemotherapy in people with metastatic pancreatic cancer that has spread. The goal is to see if the combination is safe and shrinks tumors. About 94 adults who have not had prior chemotherapy for this cancer wi…
Phase: PHASE1, PHASE2 • Sponsor: Alligator Bioscience AB • Aim: Disease control
Last updated May 11, 2026 20:38 UTC